Efficacy of gonadotropin-releasing hormone agonist and an extended-interval dosing regimen in the treatment of patients with adenomyosis and endometriosis

Gynecologic and Obstetric Investigation

Volumn 69, Issue 2, 2010, Pages 73-77

  Kang, Jia Li ^a   Wang, Xiao Xia ^a   Nie, Miao Ling ^a   Huang, Xiao Hui ^a  

^a GUANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

Author keywords

Adenomyosis; Endometriosis; Gonadotropin releasing hormone agonist; Medication

Indexed keywords

ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; TRIPTORELIN;

ADENOMYOSIS; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFICACY; DYSMENORRHEA; ENDOMETRIOSIS; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; FOLLOW UP; HOT FLUSH; HUMAN; INTERMETHOD COMPARISON; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; OBSERVATIONAL STUDY; ORGAN SIZE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SIDE EFFECT; SWEATING; TREATMENT OUTCOME; UTERUS; VAGINAL DRYNESS;

ADULT; DELAYED-ACTION PREPARATIONS; DRUG ADMINISTRATION SCHEDULE; DYSMENORRHEA; ENDOMETRIOSIS; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; GONADOTROPIN-RELEASING HORMONE; HUMANS; INJECTIONS, INTRAMUSCULAR; LUTEINIZING HORMONE; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; TRIPTORELIN; UTERUS; YOUNG ADULT;

EID: 70449647045     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000258683     Document Type: Article

References (8)

1. Broekman FJ, Bemardus RE, Berkhout G, et al: Pituitary and ovarian suppression after early follicular and mid-luteal administration of a LHRH agonist in a depot formulation decapeptyl CR. Gynecol Endocrinol 1992; 6: 153-161.
2. Filicori M, Cognigni GE, Amone R, et al: Subcutaneous administration of a depot gonodotropin-releasing hormone agonist induced profound reproductive axis suppression in women. Fertil Steril 1998; 69: 443-449.
3. Von Korff M, Ormel J, Keefe FJ, et al: Grading the severity of chronic pain. Pain 1992;50: 133-149.
4. Smith BH, Penny KI, Purves AM, et al: The Chronic Pain Grade questionnaire: validation and reliability in postal research. Pain 1997; 71: 141-147.
5. Harrison G, Wierman M, Nett T, et al: Gonadotropin-releasing hormone and its receptor in normal and malignant cells. Endocr Relat Cancer 2004; 11: 725-748.
6. Millar RP, Lu ZL, Pawson AJ, et al: Gonadotropin-releasing hormone receptors. Endocr Rev 2004; 25: 235-275.
7. Cheung T, Lo KW, Lam CW, et al: A crossover study of triptorelin and leuprorelin acetate. Fertil Steril 2000; 74: 299-305.
8. Matteo M, Caroppo E, Gliozheni O, et al: Pituitary desensitization for eight weeks after the administration of two distinct gonadotrophin-releasing hormone agonists. Eur J Obstet Gynecol Reprod Biol 2006; 126: 77-80.